loadpatents
Patent applications and USPTO patent grants for Fujimoto; Tatsuhiko.The latest application filed is for "substituted piperidine compound and use thereof".
Patent | Date |
---|---|
Heterocyclic compound and application thereof Grant 11,319,286 - Fujimoto , et al. May 3, 2 | 2022-05-03 |
Substituted piperidine compound and use thereof Grant 11,292,766 - Fujimoto , et al. April 5, 2 | 2022-04-05 |
Substituted Piperidine Compound And Use Thereof App 20220081399 - FUJIMOTO; Tatsuhiko ;   et al. | 2022-03-17 |
Heterocyclic Compound And Application Thereof App 20210269420 - FUJIMOTO; Tatsuhiko ;   et al. | 2021-09-02 |
Substituted piperidine compound and use thereof Grant 10,898,737 - Fujimoto , et al. January 26, 2 | 2021-01-26 |
Heterocyclic Compound And Application Thereof App 20200385346 - FUJIMOTO; Tatsuhiko ;   et al. | 2020-12-10 |
1,2-substituted cyclopentanes as orexin receptor antagonists Grant 10,689,373 - Fieldhouse , et al. | 2020-06-23 |
Substituted Piperidine Compound And Use Thereof App 20200115399 - FUJIMOTO; Tatsuhiko ;   et al. | 2020-04-16 |
Substituted piperidine compound and use thereof Grant 10,508,083 - Fujimoto , et al. Dec | 2019-12-17 |
Substituted Piperidine Compound And Use Thereof App 20190263843 - Fujimoto; Tatsuhiko ;   et al. | 2019-08-29 |
Substituted piperidine compound and use thereof Grant 10,287,305 - Fujimoto , et al. | 2019-05-14 |
Substituted Piperidine Compound And Use Thereof App 20190031611 - FUJIMOTO; Tatsuhiko ;   et al. | 2019-01-31 |
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists App 20180282309 - Fieldhouse; Charlotte ;   et al. | 2018-10-04 |
1,2-substituted cyclopentanes as orexin receptor antagonists Grant 10,011,588 - Fieldhouse , et al. July 3, 2 | 2018-07-03 |
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists Grant 9,790,220 - Fieldhouse , et al. October 17, 2 | 2017-10-17 |
Substituted Piperidine Compound And Use Thereof App 20170226137 - Fujimoto; Tatsuhiko ;   et al. | 2017-08-10 |
Substituted Cyclopentanes, Tetrahydrofuranes And Pyrrolidines As Orexin Receptor Antagonists App 20170073340 - Fieldhouse; Charlotte ;   et al. | 2017-03-16 |
1,2-substituted Cyclopentanes As Orexin Receptor Antagonists App 20170066744 - Fieldhouse; Charlotte ;   et al. | 2017-03-09 |
Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders Grant 9,493,432 - Fieldhouse , et al. November 15, 2 | 2016-11-15 |
Cyclopentylbenzamide Derivatives and their Use for the Treatment of Psychotic and Cognitive Disorders App 20160222030 - Fieldhouse; Charlotte ;   et al. | 2016-08-04 |
Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists Grant 9,156,829 - Fieldhouse , et al. October 13, 2 | 2015-10-13 |
Novel Compounds App 20150232460 - Fieldhouse; Charlotte ;   et al. | 2015-08-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.